Trial Profile
Clinical outcomes of patients treated with ticagrelor and prasugrelor: A prospective observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2017 New trial record